A model for evaluating the sustainability of community-directed treatment with ivermectin in the African Program for Onchocerciasis Control

International Journal of Health Planning and Management

Volumn 27, Issue 3, 2012, Pages 257-271

  Okeibunor, Joseph ^a   Bump, Jesse ^b   Zouré, Honorat G M ^c   Sékétéli, Azodoga ^d   Godin, Christine ^d   Amazigo, Uche V ^c  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b GEORGETOWN UNIVERSITY   (United States)

^c African Programme for Onchocerciasis Control (APOC)   (Burkina Faso)

^d NONE

Author keywords

APOC; Community directed treatment with ivermectin; Evaluation; Model; Sustainability

Indexed keywords

IVERMECTIN;

COMMUNITY CARE; DATA ACQUISITION; DISEASE CONTROL; HEALTH RISK; IVERMECTIN; NUMERICAL MODEL; PARASITIC DISEASE; SUSTAINABILITY;

AFRICA; ARTICLE; COMMUNITY CARE; CROSS-SECTIONAL STUDY; EDUCATION; EPIDEMIOLOGY; HEALTH CARE QUALITY; HUMAN; INTERVIEW; METHODOLOGY; NONBIOLOGICAL MODEL; ONCHOCERCIASIS; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT; STANDARD;

AFRICA; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; EDUCATION; HUMANS; INTERVIEWS AS TOPIC; IVERMECTIN; MODELS, ORGANIZATIONAL; ONCHOCERCIASIS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; SAMPLING STUDIES;

AFRICA;

EID: 84864954226     PISSN: 07496753     EISSN: 10991751     Source Type: Journal    
DOI: 10.1002/hpm.2108     Document Type: Article

References (24)

1. APOC. 2004. Guideline for Conducting an Evaluation of the Sustainability of CDTI Projects. African Programme for Onchocerciasis Control, 44 p.
2. Amazigo UV, Obono M, Dadzie KY, et al. 2002. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasit 96(Suppl 1): S75-92.
3. Amazigo UV, Boatin B. 2006. The future of onchocerciasis control in Africa. Lancet 368: 1946-1947.
4. Amazigo UV, Okeibunor J, Matovu V, Zouré H, Bump J, Sékétéli A. 2007. Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci & Med 64: 2070-2082.
5. Ashley C, Camey D. 1999. Sustainable Livelihoods: Lessons from Early Experience. Directorate for International Development (DFID), London.
6. Borus ME, Buntz CG, Tash WR. 1984. Evaluating the Impact of Health Programs: A Primer. The MIT Press, Cambridge: Massachusetts.
7. Brugha R, Starling M, Wait G. 2002. GAVI, the first steps: lessons for the global fund. Lancet 359: 435-438.
8. Clemenhagen C, Champagne F. 1986. Quality assurance as part of program evaluation: guidelines for managers and clinical departments heads. Qual Rev Bull 12: 383-387.
9. Collomb P. 1996. Demographic Evaluation of Health Programmes: Proceedings of a Seminar in Paris February 26-28, 1996, Khlat M (ed). Committee of International Cooperation in National Research in Demography, United Nations Population Fund and French Ministry of Cooperation; 3-4.
10. Davies JB. 1994. Sixty years of onchocerciasis vector control: a chronological summary with comments on eradication, reinvasion, and insecticide resistance. Annu Rev Entomol 39: 23-45.
11. Domato A. 1994. L'évaluation des programmes sociaux. In L'évaluation des Politiques et Programmes de Population, Gendreau F, Nzita Kikhela D, Guérin V (eds.). John Libbey Eurotext: Paris; 37-48.
12. Fournier C. 1992. La Place de la Démographie dans l'évaluation des Programme de Santé. Texte Soumis à Titre D'épreuve écrite de l'examen de Synthése dans le Cadre du Programme de Doctorat. Université de Montréal, 73 p.
13. Fournier C. 1994. La démographie au rendez-vous de l'évaluation des politiques et programme de santé. In L'évaluation des Politiques et Programmes de Population, Gendreau F, Nzita Kikhel D, Guerin V (eds.). John Libbey Eurotext: Paris; 49-62.
14. Fournier C. 1996. Panorama of evaluative studies: mortality indicators, data sources and method of estimation. In Demographic Evaluation of Health Programmes: Proceedings of a Seminar in Paris February 26-28, 1996, Khlat M (ed). Committee of International Cooperation in National Research in Demography, United Nations Population Fund and French Ministry of Cooperation; 15-27.
15. Hongoro C, McPake B. 2004. How to bridge the gap in human resources for health. Lancet 364: 1451-1456.
16. Kaddar M, Lydon P, Levine R. 2004. Financial challenges of immunization: a look at GAVI. B World Health Organ 82: 697-702.
17. Khlat M. 1996. Program evaluation in health field. In Demographic Evaluation of Health Programmes: Proceedings of a Seminar in Paris February 26-28, 1996, Khlat M (ed). Committee of International Cooperation in National Research in Demography, United Nations Population Fund and French Ministry of Cooperation; 5-13.
18. Okeibunor JC, Ogungbemi MK, Sama M, Gbeleou SC, Onyene U, JHF Remme 2004. Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control? Trop Med Int Health 9(8): 887-896.
19. Plaisier AP, van Oortmarssen GJ, Habbema JDF, Remme JHF, Alley ES. 1990. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Meth and Prog Bio 31: 43-56.
20. Remme JHF, De Sole G, Dadzie YK, et al. 1990. Large scale ivermectin distribution and its epidemiological consequences. Act Leidens 59: 177-191.
21. Remme JHF. 1995. The African programme for onchocerciasis control: preparing to launch. Parasitol Today 11: 403-406.
22. Rossi PH, Freeman HE. 1993. Evaluation: A Systematic Approach. Sage Publications: Newbury, London, New Delhi.
23. TDR. 1996. Community-Directed Treatment with Ivermectin: Report of a Multi-Country Study. TDR/AFT/RP/96.1 World Health Organization, Geneva.
24. World Health Organization. 1998. Guidelines for Rapid Appraisal to Assess Community Health Needs. WHO/SHS/NHP/88.4. World Health Organization. Geneva.